• Indole-3-pyruvic Acid Feedback Regulation in Auxin Biosynthe

  2026-05-22

  This study reveals a pivotal feedback mechanism in plant auxin biosynthesis, demonstrating that indole-3-pyruvic acid (IPA) directly inhibits TAA1 activity to coordinate the two enzymatic steps that produce indole-3-acetic acid (IAA). These findings clarify a core aspect of plant hormone regulation, with implications for auxin-related developmental research and metabolic engineering.

• Applied Workflows with 5-Aminolevulinic acid HCl in Heme Bio

  2026-05-22

  5-Aminolevulinic acid HCl empowers precision in heme biosynthesis research, bridging host-pathogen interaction studies with translational oncology. This guide details experimental setup, protocol optimizations, and troubleshooting tips, leveraging APExBIO’s high-purity reagent for reproducible, cutting-edge results.

• Scenario-Driven Solutions for Apoptosis Research Using Boc-D

  2026-05-21

  This article addresses key laboratory challenges in apoptosis and inflammation studies, demonstrating how Boc-D-FMK (SKU A1904) from APExBIO provides reproducible, robust solutions. Through scenario-based Q&A, researchers gain practical insights, protocol parameters, and evidence-based guidance for optimizing cell viability and cytotoxicity assays.

• Acifran in Lipid Metabolism: Mechanistic Insight & Translati

  2026-05-21

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) is redefining lipid metabolism research as a selective agonist for HM74A/GPR109A and GPR109B receptors. This thought-leadership article synthesizes recent cryo-EM structural breakthroughs, delivers practical experimental guidance, and analyzes the translational potential of Acifran as a hypolipidemic agent—positioning it as a critical tool for dissecting lipid signaling pathways and advancing metabolic disorder research.

• EdU Flow Cytometry Assay Kits (Cy3) for Robust Cell Cycle An

  2026-05-20

  Unlock precise, denaturation-free S-phase detection with EdU Flow Cytometry Assay Kits (Cy3), enabling multiplexed cell proliferation studies and streamlined genotoxicity testing. APExBIO’s optimized CuAAC workflow delivers superior sensitivity and workflow efficiency, transforming experimental reproducibility in cancer and pharmacodynamic research.

• QPRT Drives Breast Cancer Invasion via P2Y11 and Myosin Path

  2026-05-20

  Liu et al. reveal that quinolinate phosphoribosyltransferase (QPRT) promotes breast cancer invasiveness by enhancing myosin light chain phosphorylation through purinergic P2Y11 receptor signaling. Pharmacological inhibition, including the use of a selective P2Y11 antagonist, reverses these effects, offering mechanistic insight into NAD+ metabolism’s role in tumor progression and potential intervention points.

• YM-155 hydrochloride: Precision Survivin Inhibitor Workflows

  2026-05-19

  YM-155 hydrochloride enables highly selective targeting of survivin, empowering robust apoptosis inhibitor research in diverse cancer models. This guide delivers advanced experimental workflows, protocol parameters, and actionable troubleshooting strategies to unlock its full potential.

• Brefeldin A in ER Stress and Cancer: Applied Workflows & Tip

  2026-05-19

  Explore how Brefeldin A (BFA) transforms experimental design in ER stress, vesicular transport, and cancer cell apoptosis. This guide bridges foundational mechanisms with advanced workflow optimization, featuring troubleshooting tips and insights drawn from both peer-reviewed research and recent biomarker discoveries in vascular biology.

• Sulfaphenazole: CYP2C9 Inhibitor Workflows & Applied Insight

  2026-05-18

  Sulfaphenazole, a selective CYP2C9 inhibitor, empowers researchers to dissect drug metabolism, vascular function, and antibacterial mechanisms in precise, reproducible assays. This article translates the latest bench science—including optimization of sulfonamide derivatives—into actionable protocols and troubleshooting strategies for advanced translational studies.

• Sulfo-Cy5 Carboxylic Acid: Advancing Translational Fluoresce

  2026-05-18

  This thought-leadership article dissects the mechanistic innovations and strategic advantages of Sulfo-Cy5 carboxylic acid for translational researchers. Bridging mucosal immunity, neuroscience, and advanced fluorescence imaging, we reveal how this dye from APExBIO redefines workflow fidelity, sensitivity, and reproducibility—while providing actionable, evidence-backed protocol guidance and a realistic outlook for immunological translation.

• Vorinostat Modulates Protein Expression from mRNA Lipoplexes

  2026-05-17

  This study investigates how vorinostat, a histone deacetylase inhibitor, affects protein expression following the administration of mRNA lipoplexes in vitro and in vivo. The findings reveal that vorinostat enhances luciferase expression in cultured cells at low concentrations but has limited impact on in vivo protein output, guiding future strategies for mRNA delivery optimization.

• 2-NBDG for Glucose Uptake: Protocols, Workflows, and Pitfall

  2026-05-16

  2-NBDG, a fluorescently labeled glucose analog from APExBIO, enables rapid and quantitative assessment of cellular glucose uptake across diverse models. This guide details optimized protocols, advanced applications in cancer and metabolic research, and practical troubleshooting to maximize assay reliability and data clarity.

• Sulfo-Cy5 Carboxylic Acid: Precision Fluorescent Dye for Lif

  2026-05-15

  Sulfo-Cy5 carboxylic acid delivers superior water solubility and consistent fluorescence, enabling robust protein and peptide labeling without organic solvents. Its minimized fluorescence quenching and compatibility with advanced nano-adjuvant workflows make it the dye of choice for demanding imaging and immunological assays.

• DCPS as a Novel m7G Biomarker in Diabetic Foot Ulcer Healing

  2026-05-15

  This study identifies the decapping scavenger enzyme (DCPS), an m7G-related gene, as a novel biomarker that regulates epithelial cell function in diabetic foot ulcers (DFU). By integrating transcriptomic analyses and functional assays, the research elucidates how DCPS modulates cell cycle progression, proliferation, and migration, providing new insights for targeted DFU therapies.

• FAST Platform Enables Food-Grade Nutraceutical Nanoparticles

  2026-05-14

  This study introduces Facilitated Self-Assembling Technology (FAST) as a surfactant-free, food-grade approach for producing stable nanoparticles of nutraceuticals such as curcumin and resveratrol. The method improves bioavailability and colloidal stability, offers regulatory compliance, and demonstrates cellular compatibility, positioning FAST as a scalable solution for next-generation nutritional supplements.

16126 records 1/1076 page Next 12345 下5页 Last page